Gain hands-on experience testing the identity of botanical ingredients
March 29 to 31 in Wilmington, NC
IADSA December 2016 Newsflash
This issue of the IADSA Newsflash includes an update on the Association of Southeast Asian Nations (ASEAN) Agreement on Regulatory Framework for Health Supplements deadline for implementation, which will be pushed back to March 2023.
Regulatory experts provide a road map to FSMA understanding requirements and compliance
Webinar recorded Dec. 15, 2016. Member cost: $199. Nonmember cost: $499.
Learn the elements of 21 CFR 111 / current Good Manufacturing Practice (cGMP) regulations that FDA inspections have been focusing on recently
Webinar recorded Dec. 13, 2016. Member cost: $199. Nonmember cost: $499.
Draft NDI guidance fails to achieve FDA's stated goals and is contrary to intent of the law
In comments submitted to the Food and Drug Administration (FDA), the American Herbal Products Association (AHPA) expressed concern that the latest revision of draft guidance for New Dietary Ingredients (NDIs) is unlikely to achieve FDA's stated goals and is contrary to the intent of the law in numerous areas.
DEA should avoid restricting research on new medical uses, health benefits, or other uses for botanicals
In comments submitted last week to the Drug Enforcement Agency (DEA), the American Herbal Products Association (AHPA) urged the agency to refrain from using its authority to effectively remove a plant from the existing marketplace because naturally occurring constituents become scheduled under the Controlled Substances Act (CSA).
Many personal care products and dietary supplements are produced in compliance with USDA's National Organic Progam
AHPA stressed that non-food products, including personal care products, may be agricultural products that can comply with the United States Department of Agriculture (USDA) National Organic Program (NOP).
HHS Secretary has authority to create exceptions to dietary supplement definition
The American Herbal Products Association (AHPA) recommends the Secretary of Health and Human Services (HHS) consider initiating rulemaking to declare vinpocetine to be lawful dietary ingredient in comments submitted to the Food and Drug Administration (FDA).
Guidance helps companies inform consumers and comply with federal regulations
The American Herbal Products Association (AHPA) has published slack-fill guidance to help the regulated supplement industry inform consumers and comply with all relevant federal requirements.
Ayurvedic Products Committee works to promote responsible commerce of Ayurvedic ingredients and products
The American Herbal Products Association (AHPA) has approved the reappointment of Wynn Werner and P K Davè as co-chairs of the AHPA Ayurvedic Products Committee during the AHPA Board of Trustees meeting at SupplySide West in Las Vegas on Oct. 5.